Cargando…

Effect of anti-tuberculosis treatment on the systemic levels of tissue inhibitors of metalloproteinases in tuberculosis – Diabetes co-morbidity

OBJECTIVES: To study the association of Tissue inhibitors of matrix metalloproteinases (TIMP) levels with tuberculosis-diabetes comorbidity (TB-DM) comorbidity at baseline and in response to anti-TB treatment (ATT). METHODS: We examined the levels of TIMP-1, -2, -3 and -4 in pulmonary tuberculosis a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kumar, Nathella Pavan, Moideen, Kadar, Viswanathan, Vijay, Sivakumar, Shanmugam, Hissar, Syed, Kornfeld, Hardy, Babu, Subash
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8100611/ https://www.ncbi.nlm.nih.gov/pubmed/33997311 http://dx.doi.org/10.1016/j.jctube.2021.100237

Ejemplares similares

Systemic RAGE ligands are upregulated in tuberculosis individuals with diabetes co-morbidity and modulated by anti-tuberculosis treatment and metformin therapy
por: Kumar, Nathella Pavan, et al.
Publicado: (2019)

Plasma Eicosanoid Levels in Tuberculosis and Tuberculosis-Diabetes Co-morbidity Are Associated With Lung Pathology and Bacterial Burden
por: Pavan Kumar, Nathella, et al.
Publicado: (2019)

Association of Plasma Matrix Metalloproteinase and Tissue Inhibitors of Matrix Metalloproteinase Levels With Adverse Treatment Outcomes Among Patients With Pulmonary Tuberculosis
por: Kumar, Nathella P., et al.
Publicado: (2020)

Acute Phase Proteins Are Baseline Predictors of Tuberculosis Treatment Failure
por: Kumar, Nathella Pavan, et al.
Publicado: (2021)

Elevated levels of matrix metalloproteinases reflect severity and extent of disease in tuberculosis-diabetes co-morbidity and are predominantly reversed following standard anti-tuberculosis or metformin treatment
por: Kumar, Nathella P., et al.
Publicado: (2018)

Heightened circulating levels of antimicrobial peptides in tuberculosis—Diabetes co-morbidity and reversal upon treatment
por: Kumar, Nathella Pavan, et al.
Publicado: (2017)

Chitinase and indoleamine 2, 3-dioxygenase are prognostic biomarkers for unfavorable treatment outcomes in pulmonary tuberculosis
por: Kumar, Nathella Pavan, et al.
Publicado: (2023)

Plasma chemokines are biomarkers of disease severity, higher bacterial burden and delayed sputum culture conversion in pulmonary tuberculosis
por: Kumar, Nathella P., et al.
Publicado: (2019)

Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases Are Potential Biomarkers of Pulmonary and Extra-Pulmonary Tuberculosis
por: Kathamuthu, Gokul Raj, et al.
Publicado: (2020)

Prediabetes is associated with the modulation of antigen-specific Th1/Tc1 and Th17/Tc17 responses in latent Mycobacterium tuberculosis infection
por: Kumar, Nathella Pavan, et al.
Publicado: (2017)

High Dimensionality Reduction and Immune Phenotyping of Natural Killer and Invariant Natural Killer Cells in Latent Tuberculosis-Diabetes Comorbidity
por: Kathamuthu, Gokul Raj, et al.
Publicado: (2022)

Decreased Frequencies of Gamma/Delta T Cells Expressing Th1/Th17 Cytokine, Cytotoxic, and Immune Markers in Latent Tuberculosis-Diabetes/Pre-Diabetes Comorbidity
por: Kathamuthu, Gokul Raj, et al.
Publicado: (2021)

Multi-Dimensionality Immunophenotyping Analyses of MAIT Cells Expressing Th1/Th17 Cytokines and Cytotoxic Markers in Latent Tuberculosis Diabetes Comorbidity
por: Kathamuthu, Gokul Raj, et al.
Publicado: (2022)

Systems Immunology of Diabetes-Tuberculosis Comorbidity Reveals Signatures of Disease Complications
por: Prada-Medina, Cesar A., et al.
Publicado: (2017)

Persistent inflammation during anti-tuberculosis treatment with diabetes comorbidity
por: Kumar, Nathella Pavan, et al.
Publicado: (2019)

Helminth Coinfection Is Associated With Enhanced Plasma Levels of Matrix Metalloproteinases and Tissue Inhibitor of Metalloproteinases in Tuberculous Lymphadenitis
por: Kathamuthu, Gokul Raj, et al.
Publicado: (2021)

Low body mass index is associated with diminished plasma cytokines and chemokines in both active and latent tuberculosis
por: Kumar, Nathella Pavan, et al.
Publicado: (2023)

Coincident Pre-Diabetes Is Associated with Dysregulated Cytokine Responses in Pulmonary Tuberculosis
por: Kumar, Nathella Pavan, et al.
Publicado: (2014)

Impact of diabetes mellitus on immunity to latent tuberculosis infection
por: Kumar, Nathella Pavan, et al.
Publicado: (2023)

IL-27 and TGFβ mediated expansion of Th1 and adaptive regulatory T cells expressing IL-10 correlates with bacterial burden and disease severity in pulmonary tuberculosis
por: Kumar, Nathella P, et al.
Publicado: (2015)

Altered systemic levels of acute phase proteins in tuberculous lymphadenitis and modulation after treatment
por: Kathamuthu, Gokul Raj, et al.
Publicado: (2020)

Plasma chemokines as immune biomarkers for diagnosis of pediatric tuberculosis
por: Kumar, Nathella Pavan, et al.
Publicado: (2021)

Altered circulating levels of B cell growth factors and their modulation upon anti-tuberculosis treatment in pulmonary tuberculosis and tuberculous lymphadenitis
por: Kathamuthu, Gokul Raj, et al.
Publicado: (2018)

Diminished Frequencies of Cytotoxic Marker Expressing T- and NK Cells at the Site of Mycobacterium tuberculosis Infection
por: Kathamuthu, Gokul Raj, et al.
Publicado: (2020)

Differential Frequencies of Intermediate Monocyte Subsets Among Individuals Infected With Drug-Sensitive or Drug-Resistant Mycobacterium tuberculosis
por: Sampath, Pavithra, et al.
Publicado: (2022)

Circulating Angiogenic Factors as Biomarkers of Disease Severity and Bacterial Burden in Pulmonary Tuberculosis
por: Kumar, Nathella Pavan, et al.
Publicado: (2016)

Diminished plasma levels of common γ-chain cytokines in pulmonary tuberculosis and reversal following treatment
por: Kumar, Nathella Pavan, et al.
Publicado: (2017)

Discovery and Validation of a Three-Cytokine Plasma Signature as a Biomarker for Diagnosis of Pediatric Tuberculosis
por: Kumar, Nathella Pavan, et al.
Publicado: (2021)

A multi-center, prospective cohort study of whole blood gene expression in the tuberculosis-diabetes interaction
por: Queiroz, Artur T. L., et al.
Publicado: (2023)

Role of myeloid derived suppressor cells in tuberculosis infection and disease
por: Kumar, Nathella Pavan, et al.
Publicado: (2014)

NK-CD11c+ Cell Crosstalk in Diabetes Enhances IL-6-Mediated Inflammation during Mycobacterium tuberculosis Infection
por: Cheekatla, Satyanarayana Swamy, et al.
Publicado: (2016)

The recent trend in mycobacterial strain diversity among extra pulmonary lymph node tuberculosis and their association with drug resistance and the host immunological response in South India
por: Sivakumar, Shanmugam, et al.
Publicado: (2020)

Role of matrix metalloproteinases in multi-system inflammatory syndrome and acute COVID-19 in children
por: Pavan Kumar, Nathella, et al.
Publicado: (2022)

Monocyte Subsets: Phenotypes and Function in Tuberculosis Infection
por: Sampath, Pavithra, et al.
Publicado: (2018)

Decreased Frequencies of Circulating CD4(+) T Follicular Helper Cells Associated with Diminished Plasma IL-21 in Active Pulmonary Tuberculosis
por: Kumar, Nathella Pavan, et al.
Publicado: (2014)

Altered Circulating Levels of Matrix Metalloproteinases and Inhibitors Associated with Elevated Type 2 Cytokines in Lymphatic Filarial Disease
por: Anuradha, Rajamanickam, et al.
Publicado: (2012)

Coincident Helminth Infection Modulates Systemic Inflammation and Immune Activation in Active Pulmonary Tuberculosis
por: George, Parakkal Jovvian, et al.
Publicado: (2014)

Macrophage Apoptosis in Tuberculosis
por: Lee, Jinhee, et al.
Publicado: (2009)

Aging increases the systemic molecular degree of inflammatory perturbation in patients with tuberculosis
por: Oliveira-de-Souza, Deivide, et al.
Publicado: (2020)

IL-10 Dependent Suppression of Type 1, Type 2 and Type 17 Cytokines in Active Pulmonary Tuberculosis
por: Kumar, Nathella Pavan, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_ibi7ktk0a5j356qlkd76jnsucl